The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial
Authors
Keywords
-
Journal
Lancet Gastroenterology & Hepatology
Volume 7, Issue 1, Pages 49-59
Publisher
Elsevier BV
Online
2021-11-03
DOI
10.1016/s2468-1253(21)00299-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease-new insights into dietary disease triggers
- (2020) Michael Logan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn’s Disease
- (2020) Rotem Sigall Boneh et al. Clinical Gastroenterology and Hepatology
- Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable
- (2020) Henit Yanai et al. Clinical Gastroenterology and Hepatology
- The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction
- (2019) Michael Logan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
- (2019) Tal Engel et al. DIGESTIVE AND LIVER DISEASE
- Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
- (2019) Mark Löwenberg et al. GASTROENTEROLOGY
- Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial
- (2019) Arie Levine et al. GASTROENTEROLOGY
- Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease
- (2019) Nisha B Shah et al. INFLAMMATORY BOWEL DISEASES
- ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
- (2019) Joana Torres et al. Journal of Crohns & Colitis
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
- Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
- (2018) Johan Burisch et al. GUT
- Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
- (2018) Arie Levine et al. GUT
- Early intervention in Crohn’s disease: towards disease modification trials
- (2017) Silvio Danese et al. GUT
- Patients with Crohnʼs Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab
- (2017) Loic Guerbau et al. INFLAMMATORY BOWEL DISEASES
- Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn’s Disease: Results From the GROWTH CD Study
- (2017) Noa Cohen-Dolev et al. Journal of Crohns & Colitis
- A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence?
- (2017) Tim R A van den Heuvel et al. Journal of Crohns & Colitis
- Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe
- (2017) Fanni Rencz et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s Disease
- (2016) Peter Brown et al. Journal of Crohns & Colitis
- Long-term evolution and predictive factors of mild inflammatory bowel disease
- (2016) C. Reenaers et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
- (2015) E. Safroneeva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Partial Enteral Nutrition with a Crohnʼs Disease Exclusion Diet Is Effective for Induction of Remission in Children and Young Adults with Crohnʼs Disease
- (2014) Rotem Sigall-Boneh et al. INFLAMMATORY BOWEL DISEASES
- Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn’s disease
- (2013) Zubin Grover et al. JOURNAL OF GASTROENTEROLOGY
- Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity
- (2010) Severine Vermeire et al. Clinical Gastroenterology and Hepatology
- Early Crohn disease: a proposed definition for use in disease-modification trials
- (2010) L. Peyrin-Biroulet et al. GUT
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts
- (2009) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search